| Outgoing Relation(s) |
| tumour antigen (CHEBI:144829) is a antigen (CHEBI:59132) |
| Incoming Relation(s) |
| O-[N-acetyl-α-neuraminyl-(2→6)-N-acetyl-α-D-galactosaminyl]-serine (CHEBI:234084) has role tumour antigen (CHEBI:144829) |
| N-glycolylneuraminyllactosylceramide (CHEBI:144806) has role tumour antigen (CHEBI:144829) |
| O-(N-acetyl-α-D-galactosaminyl)-L-serine (CHEBI:53608) has role tumour antigen (CHEBI:144829) |
| O-(N-acetyl-α-D-galactosaminyl)-L-threonine (CHEBI:53609) has role tumour antigen (CHEBI:144829) |
| O-[N-acetyl-α-neuraminyl-(2→6)-N-acetyl-α-D-galactosaminyl]-threonine (CHEBI:234086) has role tumour antigen (CHEBI:144829) |
| disialosyl Gb5(2−) (CHEBI:140624) has role tumour antigen (CHEBI:144829) |
| α-Neu5Ac-(2→3)-β-D-Gal-(1→3)-[α-L-Fuc-(1→4)]-D-GlcNAc (CHEBI:61793) has role tumour antigen (CHEBI:144829) |
| α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) has role tumour antigen (CHEBI:144829) |
| β-D-Galp-(1→3)-[α-L-Fucp-(1→4)]-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-[α-L-Fucp-(1→3)]-D-GlcpNAc (CHEBI:194543) has role tumour antigen (CHEBI:144829) |
